Newborns at risk of COVID-19, the story continues.
Malika D ShahNicholas MillerOla Didrik SaugstadPublished in: Journal of perinatal medicine (2024)
After more than 4 years of the SARS-CoV-2 pandemic, a great deal of knowledge on how this virus affects pregnant women, the fetus and the newborn has accumulated. Guidelines for mode of delivery, cord clamping, skin to skin, breastfeeding, and rooming-in have become uniform across the world. Vaccination has considerably improved outcomes, but hesitancy amongst pregnant patients and the emergence of variants remain challenged and SARS-CoV-2 positivity during pregnancy continues to be associated with an increased risk of maternal complications, premature delivery and higher neonatal mortality and morbidity. An emerging body of data now exists on the effect of SARS-CoV-2 in pregnancy on early neonatal outcomes, medical education in obstetrics and pediatrics, and longer-term developmental outcomes. In this article, we review the development in this field since our last review.
Keyphrases
- sars cov
- pregnant women
- respiratory syndrome coronavirus
- end stage renal disease
- medical education
- coronavirus disease
- pregnancy outcomes
- preterm infants
- healthcare
- newly diagnosed
- chronic kidney disease
- risk factors
- soft tissue
- gestational age
- metabolic syndrome
- cardiovascular events
- peritoneal dialysis
- type diabetes
- electronic health record
- adipose tissue
- machine learning
- cardiovascular disease
- body mass index
- deep learning
- patient reported
- weight gain